Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Mar 31;2(4):345–352. doi: 10.1158/1940-6207.CAPR-08-0178

TABLE 2.

Characteristics of study participants by UGT1A1 genotype

UGT1A1 *1/*1
n=29 (41%)
UGT1A1 *1/*28
n=36 (51%)
UGT1A1 *28/*28
n=5 (7%)
P valuea
Age (yr) 32 ± 7.16b 33 ± 5.50 31 ± 6.02 0.74
Height (m) 1.7 ± 0.11 1.7 ± 0.09 1.7 ± 0.14 0.79
Weight (kg) 71.0 ± 15.96 68.4 ± 13.86 72.74 ± 12.37 0.93
BMI (kg/m2) 20.7 ± 3.8 20.1 ± 3.3 24.4 ± 2.4 0.98
Female (%) 45% (13) 55% (20) 60% (3) 0.64
Race (%)
  Caucasian 48% (14) 72% (26) 60% (3) 0.08
  Asian 48% (14) 17% (6) 40% (2)
  Other* 0.03% (1) 0.11% (4) 0
GSTT1/GSTM1 genotype 0.96
  (+/+) (46% female) 12 12 2
  (−/+) (50% female) 11 17 2
  (−/−) (64% female) 6 7 1
Serum Bilirubinc (µmol/L)
  Total 14.02 ± 4.96 14.02 ± 4.79 25.31 ± 9.75 0.01
  Direct 1.88 ± 0.68 1.88 ± 0.51 3.25 ± 1.03 0.01
  Indirect 12.14 ± 4.45 12.14 ± 4.45 22.06 ± 8.89 0.02
a

Tests for a trend across UGT1A1 genotypes (χ2)

b

Mean ± SD

c

When consuming habitual diets

*

Other includes African Americans and Pacific Islanders